For context, Medicaid spending on GLP-1 drugs in Pennsylvania was $1.3bn in 2025 - a whopping twice as much as the previous year
Seized shipments represent both financial loss and potential legal complications
Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation
This was because they were unconvinced an appropriate regulatory route could be found for proceeding with the substance for obesity
Sleep Support+ GLP-1/GIP Contains Tirzepatide, NAD+, Vitamin B12, Magnesium, and L-Theanine Compounded oral blend of Tirzepatide, NAD+, Vitamin B12, Magnesium, and L-Theanine, formulated to help support relaxation, balanced metabolism, and restorative sleep patterns
Complications of obesity